Results 121 to 130 of about 6,372 (199)

4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action. [PDF]

Elife
Rosenthal M, Goldberg DE.
europepmc   +1 more source

Impact of intermittent preventive treatment for malaria in pregnancy with sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, and their combination on infant outcomes: A randomized controlled trial. [PDF]

Clin Infect Dis
Nankabirwa JI, Kakuru A, Nguyen AT, Roh ME, Aguti M, Adrama H, Kizza J, Olwoch P, Camanag K, Benjamin-Chung J, Rosenthal PJ, Kamya MR, Dorsey G, Jagannathan P.   +13 more
europepmc   +1 more source

A systematic review and meta-analysis of clinical trials comparing arterolane-piperaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria. [PDF]

J Postgrad Med
Mondal A, Basu A, Modak DC, Goswami RP.
europepmc   +1 more source

Socio-demographic characteristics and parasite density patterns of Plasmodium knowlesi Malaria in Aceh, Indonesia: insights from hospital-based data. [PDF]

Infection
Maulana T, Marthoenis M, Almira CS, Moe S, Abas AL, Htay MNN.   +5 more
europepmc   +1 more source

Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated <i>Plasmodium falciparum</i> malaria in Ghana, 2023. [PDF]

Front Public Health
Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, Amoako EO, Quashie N, Owusu-Antwi F, Koram KA, Malm KL.   +10 more
europepmc   +1 more source

Intestinal permeability studies for piperaquine from dihydroartemisinin—piperaquine antimalarial product in the presence of lamivudine [PDF]

Journal of Applied Pharmaceutical Science, 2018
openaire   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Pregnant women's acceptability of intermittent preventive treatment with dihydroartemisinin-piperaquine from user and provider's perspectives: qualitative findings from the pilot implementation in Papua, Indonesia. [PDF]

BMC Pregnancy Childbirth
Hoyt J, Candrawati F, Hafidz F, Mulyadi AWE, Kenangalem E, Laksanawati IS, Ubra R, Poespoprodjo JR, Hill J.   +8 more
europepmc   +1 more source

Agent-based simulation of seasonal malaria chemoprevention strategy in Southern Tanzania: comparing dihydroartemisinin-piperaquine with or without primaquine. [PDF]

Malar J
Mfala CT, Nyambo DG, Mwaiswelo RO, Tchuenche JM, Clemen T.   +4 more
europepmc   +1 more source

Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally? [PDF]

Lancet Glob Health
Unger HW, Ataide R, Roh ME, Rahman A, Price RN, van Eijk AM, Dorsey G, Ter Kuile FO, Rogerson SJ.   +8 more
europepmc   +1 more source